Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug more accessible for some patients. While these changes may help some ...

Starting Zepbound dosage (first 4 weeks) 2.5 mg once per week Maintenance dosage ... Zepbound comes as a solution in a single-dose prefilled pen or single-dose vial for use with a syringe and ...

Last summer, Lilly started selling vials of the 2.5 mg and 5 mg doses of Zepbound online through its ... price of $1,086.37 per monthly injector pen. Wegovy’s maker, Novo Nordisk, is charging ...

The collaboration connects Noom users with Eli Lilly’s pharmacy provider, GiftHealth, to facilitate access to Zepbound single-dose vials for individuals with a prescription, according to a March ...

Zepbound is also available in a range of doses from 2.5 mg to 15 mg per 0.5 mL in a single-dose pen (autoinjector), with recommended maintenance dosages of 5 mg, 10 mg, or 15 mg injected ...

Zepbound has now been added to that ... to Eli Lilly’s reduced-cost GLP-1 in doses from 2.5 mg to 15 mg and single vial and single pen injections. Lilly recently launched additional doses ...

Before launching the Zepbound vials in 2024, Eli Lilly offered the drug only in a single-dose injector pen, used once weekly, in doses ranging from 2.5 mg to 15 mg. “We launched the vials last ...

Last summer, Lilly started selling vials of the 2.5 mg and 5 mg doses of Zepbound online through its ... price of $1,086.37 per monthly injector pen.